MOVE enters May with a striking disconnect: the stock has rallied 44% over the past month, yet short sellers are piling in at the fastest pace of the recent period — and borrowing remains extraordinarily expensive.
The short-side story is the defining tension here. Short interest on the free float climbed to roughly 5.9% as of April 30, up from around 2.7% on April 23 — a near-doubling in just one week. The raw share count jumped 64% over the same span. That kind of acceleration on a micro-cap stock with a ~$18 million market cap is unusual. Days to cover from the FINRA fortnightly data runs at just one day, meaning the short book is thin in absolute terms, but the pace of build is not.
The borrow market makes the setup more charged. Cost to borrow is running at 156% annualised — deep in hard-to-borrow territory. That's actually a come-down from mid-April, when it was closer to 210%, but the level remains extreme. Availability is 390% of short interest, which means the lending pool is not yet strained relative to what shorts have drawn. That reading is comfortably loose — there is room for the short book to grow further without triggering a squeeze on supply. The borrow crunch, then, is about price, not about quantity. Someone is paying a significant carry cost to hold a bearish position against a stock that just more than doubled off its March lows.
The price chart captures the tension cleanly. closed at $14.71 on May 1, down 7.5% on the day and 14% over the week, after touching close to $18 in late April. That peak came against a backdrop of a 140%-plus gain year-to-date. The short build and the price pullback are happening together, but the question is whether the shorts are correct that the move has run too far, or whether the stock finds support at these levels. The RSI14 at 51.7 is neutral — neither technically extended nor collapsed.
The institutional ownership picture is thin, which matters in a stock this small. Vanguard holds roughly 1.4% of shares. Two individuals — Seth Demsey (2.8%) and Jay Crystal (2.0%) — sit atop the holder list with recently initiated positions. With only four reported institutional holders and a float of around 867,000 shares, liquidity is extremely limited. The insider data on file (predominantly CEO and CFO sells from January at prices between $19 and $23) is stale and pre-dates the current price level — the executives sold above where the stock currently trades. No fresher insider signal is available.
No analyst coverage exists in the ORTEX dataset, and valuation multiples are stale. The next reported earnings date is June 18. The one historical earnings reaction on record showed a modest decline of 2.3% on the day and 5% over five days — not a dramatic mover on results.
The clearest watchpoint heading into June is whether the short interest build continues to accelerate into earnings, and whether borrow costs stay elevated enough to force some covering before the print.
See the live data behind this article on ORTEX.
Open MOVE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
